Objective The relative risk of SARS–CoV‐2 infection and COVID‐19 disease severity among
people with rheumatic and musculoskeletal diseases (RMDs) compared to those without …

Objectives COVID-19 pandemic has already had a tremendous impact on the process of
human society; the survival of mankind and the healthy living environment deterioration with …

Since the outset of the COVID-19 pandemic, numerous risk factors for severe disease have
been identified. Whether patients with rheumatic diseases, especially those receiving …

Objective In earlier studies, patients with rheumatic and musculoskeletal disease (RMD)
who got infected with COVID-19 had a higher risk of mechanical ventilation than …

Patients with rheumatic diseases are often more susceptible to different bacteria and viruses
because of immune impairment, but it is not clear whether there is a higher risk of infection …

Objectives COVID-19 outcomes in people with rheumatic diseases remain poorly
understood. The aim was to examine demographic and clinical factors associated with …

Objectives The impact of rheumatic diseases on COVID-19 infection remains poorly
investigated. Here we performed a systematic review and meta-analysis to evaluate the …

Background As the COVID-19 pandemic continues worldwide, severe COVID-19 outcomes
remain a major concern for patients with rheumatic and musculoskeletal diseases. We …

Objectives There is little known about the impact of SARS-CoV-2 on patients with
inflammatory rheumatic and musculoskeletal diseases (iRMD). We examined …

Background Over the month of April, Spain has become the European country with more
confirmed cases of COVID-19 infection, after surpassing Italy on April 2nd. The community of …